X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs IPCA LABS - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA IPCA LABS SANOFI INDIA/
IPCA LABS
 
P/E (TTM) x 30.7 28.0 109.9% View Chart
P/BV x 5.4 2.1 253.0% View Chart
Dividend Yield % 1.7 0.2 693.8%  

Financials

 SANOFI INDIA   IPCA LABS
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
IPCA LABS
Mar-17
SANOFI INDIA/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs4,560643 709.2%   
Low Rs4,400503 875.1%   
Sales per share (Unadj.) Rs1,028.5254.4 404.3%  
Earnings per share (Unadj.) Rs129.016.1 802.5%  
Cash flow per share (Unadj.) Rs186.029.8 624.6%  
Dividends per share (Unadj.) Rs68.001.00 6,800.0%  
Dividend yield (eoy) %1.50.2 869.6%  
Book value per share (Unadj.) Rs753.6194.6 387.4%  
Shares outstanding (eoy) m23.03126.20 18.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.42.3 193.4%   
Avg P/E ratio x34.735.7 97.4%  
P/CF ratio (eoy) x24.119.2 125.2%  
Price / Book Value ratio x5.92.9 201.9%  
Dividend payout %52.76.2 847.3%   
Avg Mkt Cap Rs m103,17472,300 142.7%   
No. of employees `0003.613.3 27.2%   
Total wages/salary Rs m3,5926,960 51.6%   
Avg. sales/employee Rs Th6,537.72,413.5 270.9%   
Avg. wages/employee Rs Th991.4523.2 189.5%   
Avg. net profit/employee Rs Th819.8152.4 537.7%   
INCOME DATA
Net Sales Rs m23,68632,106 73.8%  
Other income Rs m708226 313.7%   
Total revenues Rs m24,39432,332 75.4%   
Gross profit Rs m5,2814,448 118.7%  
Depreciation Rs m1,3131,730 75.9%   
Interest Rs m15241 6.2%   
Profit before tax Rs m4,6612,703 172.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,691675 250.4%   
Profit after tax Rs m2,9702,028 146.4%  
Gross profit margin %22.313.9 160.9%  
Effective tax rate %36.325.0 145.2%   
Net profit margin %12.56.3 198.5%  
BALANCE SHEET DATA
Current assets Rs m15,67317,340 90.4%   
Current liabilities Rs m6,6789,559 69.9%   
Net working cap to sales %38.024.2 156.7%  
Current ratio x2.31.8 129.4%  
Inventory Days Days76100 75.8%  
Debtors Days Days2257 39.2%  
Net fixed assets Rs m8,09820,779 39.0%   
Share capital Rs m230252 91.2%   
"Free" reserves Rs m17,08824,499 69.8%   
Net worth Rs m17,35624,553 70.7%   
Long term debt Rs m03,517 0.0%   
Total assets Rs m25,40039,595 64.1%  
Interest coverage x311.712.2 2,549.8%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.90.8 115.0%   
Return on assets %11.85.7 205.1%  
Return on equity %17.18.3 207.2%  
Return on capital %26.910.5 256.9%  
Exports to sales %24.548.6 50.3%   
Imports to sales %28.014.2 196.5%   
Exports (fob) Rs m5,80115,617 37.1%   
Imports (cif) Rs m6,6274,571 145.0%   
Fx inflow Rs m7,14515,617 45.8%   
Fx outflow Rs m6,8465,828 117.5%   
Net fx Rs m2999,790 3.1%   
CASH FLOW
From Operations Rs m3,2262,764 116.7%  
From Investments Rs m-1,555-1,432 108.6%  
From Financial Activity Rs m-1,818-1,591 114.2%  
Net Cashflow Rs m-147-259 56.8%  

Share Holding

Indian Promoters % 0.0 45.9 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 11.4 126.3%  
FIIs % 14.6 25.3 57.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 17.4 60.3%  
Shareholders   15,184 36,892 41.2%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   TORRENT PHARMA  NATCO PHARMA  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Amid Fed and ECB Minutes, L&T, Power Grid & IOC Among Other Top Stocks to Watch Out Today(Pre-Open)

On Thursday, Indian share markets oscillated between green and red in a broad range throughout the day and ended the session with marginal gains, with Nifty holding 9,900 mark.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Aug 17, 2017 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS